Search Results - "Gerald, Christophe P.G."

Anxiolytic- and Antidepressant-like Profiles of the Galanin-3 Receptor ($Gal_3$) Antagonists SNAP 37889 and SNAP 398299 by Chad J. Swanson, Thomas P. Blackburn, Xuexiang Zhang, Zheng, Kang, Xu, Zhi-Qing David, Hökfelt, Tomas, Toni D. Wolinsky, Michael J. Konkel, Heidi Chen, Huailing Zhong, Mary W. Walker, Craig, Douglas A., Christophe P. G. Gerald, Branchek, Theresa A.

“…The neuropeptide galanin mediates its effects through the receptor subtypes$Gal_1$,$Gal_2$, and$Gal_3$and has been implicated in anxiety-and depression-related…”
Get full text

The MCH 1 receptor antagonist SNAP 94847 induces sensitivity to dopamine D 2/D 3 receptor agonists in rats and mice by Marsteller, Douglas A., Gerald, Christophe P.G., Kong, Ron, Cajina, Manuel, Craig, Douglas A., Swanson, Chad J.

“…Antidepressant treatment of two or more weeks in rats has been shown to enhance the locomotor-stimulating effects of dopamine D 2/D 3 receptor agonists. This…”
Get full text

The MCH1 receptor antagonist SNAP 94847 induces sensitivity to dopamine D2/D3 receptor agonists in rats and mice by MARSTELLER, Douglas A, GERALD, Christophe P. G, RON KONG, CAJINA, Manuel, CRAIG, Douglas A, SWANSON, Chad J

“…Antidepressant treatment of two or more weeks in rats has been shown to enhance the locomotor-stimulating effects of dopamine D(2)/D(3) receptor agonists. This…”
Get full text

Novel mechanisms to treat depression and anxiety: Will neuropeptide antagonists succeed? by Gerald, Christophe P.G., Antonijevic, Irina A., Branchek, Theresa A.

“…Current anti-depressant treatments do not completely fulfill our expectations in terms of efficacy, onset of action and side effects. For decades, both…”
Get full text